• A large-scale study, ACHIEVE, has been launched in East Africa to investigate the burden of chikungunya in Kenya and Tanzania.
• The study will screen patients with fever or neurological symptoms for chikungunya at healthcare facilities across both countries starting in 2025.
• Supported by USD 10.3 million from CEPI, the study aims to improve understanding of chikungunya and inform disease control strategies.
• The research will also provide important data to advance the development and deployment of chikungunya vaccines in affected regions.